Acetaminophen News and Research

RSS
The pain-reliever acetaminophen (also known as paracetomol) is one of the best-selling over-the-counter medications, used by more than 200 million Americans a year. It is sold under many brand names, including Tylenol, and is an ingredient in nearly 200 medications, both over-the-counter (such as Excedrin, Midol, NyQuil, and Sudafed) and prescription (such as Vicodin).
Genmed obtains marketing authorization license for paracetamol in Europe

Genmed obtains marketing authorization license for paracetamol in Europe

Positive interim results from elotuzumab Phase 1b/2 study in relapsed multiple myeloma

Positive interim results from elotuzumab Phase 1b/2 study in relapsed multiple myeloma

Patients with chronic constipation prefer Kristalose oral solution

Patients with chronic constipation prefer Kristalose oral solution

Research shows anti-microbial medications lead to acute liver failure

Research shows anti-microbial medications lead to acute liver failure

Zogenix completes enrollment in ZX002 Phase 3 study for moderate to severe pain

Zogenix completes enrollment in ZX002 Phase 3 study for moderate to severe pain

Use of aspirin and statins can reduce depression: Study

Use of aspirin and statins can reduce depression: Study

Xanodyne Pharmaceuticals decides to voluntarily remove propoxyphene from the U.S. market

Xanodyne Pharmaceuticals decides to voluntarily remove propoxyphene from the U.S. market

Merck wins third FOSAMAX bellwether trial

Merck wins third FOSAMAX bellwether trial

CMS grants Qutenza J-code to NeurogesX

CMS grants Qutenza J-code to NeurogesX

Labopharm receives notice about Activis' ANDA for OLEPTRO

Labopharm receives notice about Activis' ANDA for OLEPTRO

Labopharm receives notice of Activis' ANDA submission for generic OLEPTRO

Labopharm receives notice of Activis' ANDA submission for generic OLEPTRO

Labopharm third quarter total revenue increases to $9.6 million

Labopharm third quarter total revenue increases to $9.6 million

Childhood asthma risk linked with prenatal paracetamol exposure depends on antioxidant genes in mother

Childhood asthma risk linked with prenatal paracetamol exposure depends on antioxidant genes in mother

FDA grants Cadence marketing approval for OFIRMEV injection in management of pain and fever

FDA grants Cadence marketing approval for OFIRMEV injection in management of pain and fever

NeurogesX initiates NGX-1998 Phase 2 study in postherpetic neuralgia

NeurogesX initiates NGX-1998 Phase 2 study in postherpetic neuralgia

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

NeurogesX plans U.S. label expansion for Qutenza in HIV-associated neuropathy

NeurogesX plans U.S. label expansion for Qutenza in HIV-associated neuropathy

Elorac acquires world-wide rights to Cidoxepin

Elorac acquires world-wide rights to Cidoxepin

Acetadote Injection is now commercially available in Australia

Acetadote Injection is now commercially available in Australia

Labopharm, Paladin Labs expand commercial relationship

Labopharm, Paladin Labs expand commercial relationship